FDC launches 2 variants of Favipiravir in India at Rs 55 per tablet
Drug firm FDC Ltd has launched two variants of the COVID-19 drug Favipiravir under the brand names PiFLU and Favenza. […]
Say something
Serum-Oxford covid-19 vaccine gets DCGI nod for phase 2, 3 trials in India
The Serum Institute of India (SII) has received approval from Drug Controller General of India (DCGI) to move ahead for […]
DCGI nod to Pneumococcal Polysaccharide Conjugate Vaccine
Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine. This […]
Mylan set to launch new TB drug in India after DCGI’s approval
Multinational pharmaceutical company Mylan is working with Drug Controller General of India (DCGI) to launch pretomanid, a medicine used to […]
VG Somani appointed new Drug Controller General
VG Somani has been appointed as new Drug Controller General of India (DCGI). DCGI heads the Central Drugs Standard Control […]
Lupin gets CDSCO nod for 2nd generation antihistanine medicine
The Central Drugs Standard Control Organisation (CDSCO) has given its approval to Mumbai-based multinational pharmaceutical company Lupin Limited for Bepotastine […]
RMS Regrow gets FDA India nod for cell therapy product
The Ministry of Health and Drug Controller General of India (DCGI) have granted market authorisation for Regenerative Medical Services Regrow’s […]
-
-
Flipkart Health+ App Launched
06-04-2022
